Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program

BACKGROUND: Information on anaphylaxis among recipients of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains scarce. OBJECTIVE: To identify the observed incidence of anaphylaxis in recipients of different anti-SARS-CoV-2 vaccines. METHODS: A nationwide observa...

Descripción completa

Detalles Bibliográficos
Autores principales: Toledo-Salinas, Carla, Scheffler-Mendoza, Selma Cecilia, Castano-Jaramillo, Lina Maria, Ortega-Martell, José Antonio, Del Rio-Navarro, Blanca Estela, Santibáñez-Copado, Ana María, Díaz-Ortega, José Luis, Baptista-Rosas, Raúl, Sánchez-Novoa, Paulina, García-Grimshaw, Miguel, Valdés-Ferrer, Sergio Iván, Reyes-Terán, Gustavo, Mendoza-Hernández, David Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382604/
https://www.ncbi.nlm.nih.gov/pubmed/35976470
http://dx.doi.org/10.1007/s10875-022-01350-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382604/
https://www.ncbi.nlm.nih.gov/pubmed/35976470
http://dx.doi.org/10.1007/s10875-022-01350-1

Ejemplares similares